← Leaderboards
Sreekanth Vemulapalli
Duke University
$3,194,344
Attributed
$7,652,751
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,652,751 · 5
By mechanism
R01$3,763,867 · 2
U24$3,639,511 · 2
R43$249,373 · 1
Top collaborators
- Shrikant I Bangdiwala3 shared
- Jackie Bosch3 shared
- John Eikelboom3 shared
- Sean M O'Brien3 shared
- Manesh R Patel3 shared
- Svati H. Shah2 shared
- Anru Zhang2 shared
- Ricardo Henao Giraldo1 shared
Most similar at Duke University
Same institution · by research overlap
- Yi Zeng$5,738,137
- Zeng Yi$1,774,606
- Lawrence G Harshman$1,774,606
- Christopher Ethan Cox$12,927,755
- Firas Fuad Mussa$1,747,909
Others in their field
Other Emerging Leaders on “Mortality”
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
- Barbara Halina Braffett · George Washington University$17,931,151
Research focus
MortalityReportingSiteEnrollmentCompanionsBlood VesselsNational Heart, Lung, And Blood InstituteGuidelinesResearch PersonnelPatient CareEventProceduresCost EffectivenessQuality Of LifeMorbidity - Disease RateImageCollectionTrainingPrevalenceCardiovascular SystemCreativenessData ManagementBlood Pressure MonitorsDesign
Grant awards (12)
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$710,826
U24 · FY2025 · HL
Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders$705,314
R01 · FY2025 · HL
2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)$656,265
U24 · FY2025 · HL · contact PI
2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)$120,557
U24 · FY2025 · HL · contact PI
Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders$756,895
R01 · FY2024 · HL
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$721,106
U24 · FY2024 · HL
2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)$610,248
U24 · FY2024 · HL · contact PI
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)$820,509
U24 · FY2023 · HL
BEST-VIVA Registry (vCLI)$745,998
R01 · FY2021 · HL
BEST-VIVA Registry (vCLI)$770,362
R01 · FY2020 · HL
Machine learning driven transthoracic echocardiographic analysis and screening for cardiac amyloidosis$249,373
R43 · FY2020 · HL
BEST-VIVA Registry (vCLI)$785,298
R01 · FY2019 · HL